Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Project 2VIDA! COVID-19 Vaccine Intervention
NCT05022472Phase 4Completed
- Start
- Jul 2021
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms). Primary endpoint: Change in Vaccine Hesitancy at 4 weeks. Started Jul 2021; status: completed.
Beyond the preview
Go deeper on NCT05022472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05022472.